StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive: AVI BioPharma Inc

Enter Symbol or Keywords

AVI Biopharma Experiencing Revenue Downtrend While its Industry is in an Uptrend

Stock Quote: (NGM:AVII)

11/16/2009

1.45

-0.04

-2.68%

733,326

AVI Biopharma Experiencing Revenue Downtrend While its Industry is in an Uptrend

Last

Price Change

% Chg

Volume

New York, NY, November 16, 2009,T12-NEWS says that trailing twelve month (TTM) Revenue for AVI Biopharma (NASDAQ:AVII) for its twelve months ended September 30, 2009 decreased by -14.5% to $17,923,912 ... read full story

Website Address:	www.antivirals.com
Industry:	Vaccine, Antibodies, Immunities

Most Recent STN Exclusives

02/09/2010

Cash Flow from Operations Improves 82% for News Corp.

02/09/2010

Revenue for Coach Increases by 3.25% even though Revenue for Apparel Industry Decreases by -22.4% over Latest 12 Months

02/09/2010

Free Cash Flow for News Corp. Reaches Two Year High

02/09/2010

Cash Flow from Operations Turns Positive for Siemens' First Quarter

02/09/2010

StockDiagnostics.com Has Issued a Cashless Earnings Warning For Energy XXI

02/08/2010

Second Quarter EBITDA Turns Positive for Harris

02/08/2010

Twelve Year High in EBITDA for Amazon.com

02/08/2010

Cash Flow from Operations for McCormick Reaches Fifteen Year High

02/08/2010

EBITDA for BMC Software Reaches Thirteen Year High

02/08/2010

EBITDA for CA Reaches Nine Year High

Interactive Chart: AVII

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: AVII

11/18/2009

Three Year High in EBITDA for AVI Biopharma

11/16/2009

AVI Biopharma Experiencing Revenue Downtrend While its Industry is in an Uptrend

11/16/2009

AVI Biopharma's OPS Ranking of "8" Reiterated by StockDiagnostics.com

... more AVII exclusives

Other News Sources: AVII

02/08/2010

AVII: Jumps +2.05%; Vol +89%; Last 90 Min of Trading

02/05/2010

AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystrophy

02/04/2010

AVI BioPharma GLP Safety Pharmacology and Genotoxicity Evaluations of AVI-4658 for Duchenne Muscular Dystrophy Published in the International Journal of Toxicology

... more AVII news from other sources

Daily Market Updates

02/09/2010

Markets Close Day After Strong Rally as Concerns Ease re Greece

Stocks closed today's strong rally following speculation that the European Union will step in to bail out Greece. Germany and its European Union partners are expected to offer Greece and other troubled EU members loan guarantees. Oil climbed almost $ ... read full story